(SUZ) Suzano Papel e Celulose - Ratings and Ratios
Pulp, Paper, Tissue, Biofuel, Power
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.22% |
| Yield on Cost 5y | 2.01% |
| Yield CAGR 5y | -29.93% |
| Payout Consistency | 64.3% |
| Payout Ratio | 4.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.3% |
| Value at Risk 5%th | 33.0% |
| Relative Tail Risk | -10.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -12.34 |
| CAGR/Max DD | 0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.349 |
| Beta | 0.419 |
| Beta Downside | 0.368 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.01% |
| Mean DD | 15.89% |
| Median DD | 19.18% |
Description: SUZ Suzano Papel e Celulose January 02, 2026
Suzano S.A. (NYSE:SUZ) is a Brazil-based integrated pulp and paper producer that sells coated and uncoated printing-writing papers, paperboards, tissue, and market-fluff pulps worldwide. The firm operates two primary segments-Pulp, and Paper & Consumer Goods-and supplements its core business with activities ranging from biofuel production and port terminal operations to biotechnology, nanocrystalline pulp R&D, and forest restoration.
Key recent metrics: in 2023 Suzano generated roughly 13 million tons of pulp, delivering an EBITDA margin near 30 % and a net debt-to-EBITDA ratio of about 2.1×, reflecting a strong cash-flow profile. The company’s earnings are highly sensitive to the USD/BRL exchange rate and to global hardwood pulp prices, which have been driven upward by sustained demand for sustainable packaging in North America and Europe. Additionally, Suzano’s 2024 capital-expenditure plan includes a $1.5 billion investment in expanding its integrated forest estate, a move that aligns with ESG-focused procurement trends in the paper sector.
For a deeper, data-rich analysis of Suzano’s valuation and risk factors, you may want to explore the detailed dashboards on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 6.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 2.92 > 1.0 |
| NWC/Revenue: 57.16% < 20% (prev 45.18%; Δ 11.98% < -1%) |
| CFO/TA 0.12 > 3% & CFO 19.00b > Net Income 6.56b |
| Net Debt (83.97b) to EBITDA (30.51b): 2.75 < 3 |
| Current Ratio: 3.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.24b) vs 12m ago -1.27% < -2% |
| Gross Margin: 34.44% > 18% (prev 0.43%; Δ 3402 % > 0.5%) |
| Asset Turnover: 32.23% > 50% (prev 27.86%; Δ 4.37% > 0%) |
| Interest Coverage Ratio: 3.08 > 6 (EBITDA TTM 30.51b / Interest Expense TTM 6.42b) |
Altman Z'' 2.94
| A: 0.18 (Total Current Assets 42.58b - Total Current Liabilities 13.32b) / Total Assets 164.42b |
| B: 0.16 (Retained Earnings 26.38b / Total Assets 164.42b) |
| C: 0.12 (EBIT TTM 19.77b / Avg Total Assets 158.81b) |
| D: 0.39 (Book Value of Equity 46.63b / Total Liabilities 119.16b) |
| Altman-Z'' Score: 2.94 = A |
Beneish M -3.07
| DSRI: 0.60 (Receivables 6.13b/8.57b, Revenue 51.18b/42.68b) |
| GMI: 1.24 (GM 34.44% / 42.60%) |
| AQI: 1.01 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.20 (Revenue 51.18b / 42.68b) |
| TATA: -0.08 (NI 6.56b - CFO 19.00b) / TA 164.42b) |
| Beneish M-Score: -3.07 = AA |
ValueRay F-Score (Strict, 0-100) 64.47
| 1. Piotroski: 6.50pt |
| 2. FCF Yield: 3.39% |
| 3. FCF Margin: 10.57% |
| 4. Debt/Equity: 2.21 |
| 5. Debt/Ebitda: 2.75 |
| 6. ROIC - WACC: 6.05% |
| 7. RoE: 16.52% |
| 8. Revenue Trend: 17.89% |
| 9. EPS Trend: -14.08% |
What is the price of SUZ shares?
Over the past week, the price has changed by +2.18%, over one month by +5.91%, over three months by +11.11% and over the past year by -4.94%.
Is SUZ a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SUZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.5 | 26.6% |
| Analysts Target Price | 12.5 | 26.6% |
| ValueRay Target Price | 9.9 | 0.8% |
SUZ Fundamental Data Overview January 18, 2026
P/E Trailing = 9.64
P/E Forward = 8.569
P/S = 0.2328
P/B = 1.4183
Revenue TTM = 51.18b BRL
EBIT TTM = 19.77b BRL
EBITDA TTM = 30.51b BRL
Long Term Debt = 89.17b BRL (from longTermDebt, last quarter)
Short Term Debt = 4.64b BRL (from shortTermDebt, last quarter)
Debt = 99.81b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 83.97b BRL (from netDebt column, last quarter)
Enterprise Value = 159.66b BRL (63.38b + Debt 99.81b - CCE 3.53b)
Interest Coverage Ratio = 3.08 (Ebit TTM 19.77b / Interest Expense TTM 6.42b)
EV/FCF = 29.52x (Enterprise Value 159.66b / FCF TTM 5.41b)
FCF Yield = 3.39% (FCF TTM 5.41b / Enterprise Value 159.66b)
FCF Margin = 10.57% (FCF TTM 5.41b / Revenue TTM 51.18b)
Net Margin = 12.82% (Net Income TTM 6.56b / Revenue TTM 51.18b)
Gross Margin = 34.44% ((Revenue TTM 51.18b - Cost of Revenue TTM 33.55b) / Revenue TTM)
Gross Margin QoQ = 30.44% (prev 35.26%)
Tobins Q-Ratio = 0.97 (Enterprise Value 159.66b / Total Assets 164.42b)
Interest Expense / Debt = 1.83% (Interest Expense 1.82b / Debt 99.81b)
Taxrate = 35.08% (1.06b / 3.02b)
NOPAT = 12.83b (EBIT 19.77b * (1 - 35.08%))
Current Ratio = 3.20 (Total Current Assets 42.58b / Total Current Liabilities 13.32b)
Debt / Equity = 2.21 (Debt 99.81b / totalStockholderEquity, last quarter 45.12b)
Debt / EBITDA = 2.75 (Net Debt 83.97b / EBITDA 30.51b)
Debt / FCF = 15.53 (Net Debt 83.97b / FCF TTM 5.41b)
Total Stockholder Equity = 39.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.13% (Net Income 6.56b / Total Assets 164.42b)
RoE = 16.52% (Net Income TTM 6.56b / Total Stockholder Equity 39.73b)
RoCE = 15.33% (EBIT 19.77b / Capital Employed (Equity 39.73b + L.T.Debt 89.17b))
RoIC = 9.67% (NOPAT 12.83b / Invested Capital 132.64b)
WACC = 3.62% (E(63.38b)/V(163.19b) * Re(7.46%) + D(99.81b)/V(163.19b) * Rd(1.83%) * (1-Tc(0.35)))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.51%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈3.47b ; Y1≈2.28b ; Y5≈1.04b
Fair Price DCF = N/A (negative equity: EV 33.13b - Net Debt 83.97b = -50.84b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -14.08 | EPS CAGR: -21.36% | SUE: -0.07 | # QB: 0
Revenue Correlation: 17.89 | Revenue CAGR: 1.55% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=1.16 | Chg30d=+0.272 | Revisions Net=+1 | Growth EPS=-44.5% | Growth Revenue=+13.4%
Additional Sources for SUZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle